503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.89%
Both yoy net incomes decline, with BB at -19.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
12.98%
D&A growth well above BB's 20.06%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-1057.14%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
2.78%
Less SBC growth vs. BB's 66.67%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
86.98%
Well above BB's 123.65% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
175.85%
AR growth while BB is negative at -275.62%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-105.61%
Negative yoy inventory while BB is 217.48%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-164.77%
Both negative yoy AP, with BB at -489.66%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
1.75%
Lower 'other working capital' growth vs. BB's 144.48%. David Dodd would see fewer unexpected short-term demands on cash.
-0.64%
Negative yoy while BB is 142.50%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
63.66%
Operating cash flow growth below 50% of BB's 1918.37%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-50.40%
Both yoy lines negative, with BB at -8.85%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
99.03%
Acquisition spending well above BB's 6.80%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-138.39%
Negative yoy purchasing while BB stands at 72.45%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-12.33%
Both yoy lines are negative, with BB at -49.15%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
223.63%
Growth well above BB's 99.87%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-119.85%
We reduce yoy invests while BB stands at 55.15%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
65.30%
Issuance growth of 65.30% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
1.82%
We have some buyback growth while BB is negative at -927.27%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.